From a clinical point of view, several studies have depicted a correlation between high levels of tumour PrPC—as inferred through immuno-histochemistry—and metastasis in patients with breast [89], gastric [83,90] and colorectal [31,56,86] cancer. The gene discussed is PRNP; the disease is cancer.